Jump to content

Eko Health Inc.

From Wikipedia, the free encyclopedia
Eko
Company typePrivate
IndustryHealth
Founded2014
Founder
  • Connor Landgraf (CEO)
  • Jason Bellet
  • Tyler Crouch
Headquarters
Oakland, CA
Number of employees
153
Websitewww.ekohealth.com

Eko Health Inc. (Eko) is an American healthcare technology company that develops medical devices, software, and clinical support AI to detect cardiovascular and pulmonary disease.[1]

History

[edit]

Eko was founded in 2013 by Connor Landgraf, Jason Bellet, and Tyler Crouch. Landgraf was inspired to create Eko after seeing the limitations of traditional stethoscopes during his studies in biomedical engineering at the University of California, Berkeley and recruited his classmates Bellet and Crouch to join him.[2]

In 2015, Eko received FDA clearance for its first product, CORE, a digital attachment for traditional stethoscopes with a compatible smartphone application.[3] In 2017, Eko received FDA clearance for the DUO, a combined digital stethoscope ECG that could be used without a traditional stethoscope.[4] In 2018, Eko's low ejection fraction screening algorithm, developed with the Mayo Clinic, received a ‘Breakthrough Device’ designation from the FDA.[5]

In 2020, Eko announced $65 million in funding,[6] and a collaboration with 3M.[7] Eko raised an additional $30M in funding in 2022,[8] and received FDA clearance for its murmur analysis software.[9]

In 2023, Eko received FDA-clearance for the CORE500 digital stethoscope, which combines artificial intelligence (AI) software, high-fidelity audio, full-color display and 3-lead electrocardiogram (ECG). CORE500 offers compatibility with Eko’s Sensora platform, which uses artificial intelligence (AI) in cardiac disease detection. [10]

References

[edit]
  1. ^ "Why Patience Was This Healthcare Company's Biggest Asset". Inc. Retrieved 29 May 2023.
  2. ^ "Take a Deep Breath, Then Check Your Smartphone". New York Times. 2 September 2015. Retrieved 29 May 2023.
  3. ^ "Smart stethoscope gets FDA stamp of approval". CNN. 2 September 2015. Retrieved 29 May 2023.
  4. ^ "Forbes Under 30 Alumni Score FDA Clearance For New Heart Monitor". Forbes. 7 June 2017. Retrieved 29 May 2023.
  5. ^ "New technology can screen for heart failure during routine physicals". CNBC. 23 December 2019. Retrieved 29 May 2023.
  6. ^ "Digital-Health Startup Eko to Expand With $65 Million Venture Financing". Wall Street Journal. 9 November 2020. Retrieved 29 May 2023.
  7. ^ "3M and Eko collaborate on stethoscopes". MassDevice. 19 October 2020. Retrieved 29 May 2023.
  8. ^ "Eko expands algorithmic heart problem detection and lands $30M Series C extension". TechCrunch. 22 March 2022. Retrieved 29 May 2023.
  9. ^ "Eko secures heart murmur AI clearance for digital stethoscopes". Fierce Biotech. 13 July 2022. Retrieved 29 May 2023.
  10. ^ "Eko launches digital stethoscope with heart disease detection AI". Mass Device. 27 June 2023. Retrieved 13 July 2023.